The typical triad of HHS is hyperglycemia, hyperosmolality, and a mild metabolic acidosis. Specific laboratory values that suggest the diagnosis of HHS are a blood glucose Ͼ33 mmol/L (Ͼ600 mg/dL) and a serum osmolality Ͼ320 mmol/kg (Ͼ320 mOsm/kg) in the absence of severe acidosis (pH Ͼ 7.3) and ketosis (4, 5) . These laboratory findings can often be differentiated from the lower glucose levels, metabolic acidosis, and ketosis found in diabetic ketoacidosis (DKA). However, HHS does not always present as its typical diagnostic triad. There is considerable overlap with DKA producing a wide spectrum of presentations, making the diagnosis difficult (Table 1) (5) .
HHS may be the presentation of newonset T2DM or may develop as a compli-cation of inadequate control. It can also present in children secondary to causes other than T2DM (6 -9) and present as a complication of type 1 diabetes (4, 10 -12) . The condition is well recognized in adults and is associated with a 10 -50% mortality rate (5, 13) . The mortality rate in pediatric patients is unknown, but recent case reports demonstrate extremely poor outcomes (13, 14) . The course, complications, and management in children have, until recently, rarely been discussed in the literature (11, (15) (16) (17) (18) , and there have been no published studies addressing treatment strategies. Here, we report four pediatric patients with T2DM who presented with HHS. This case series has been approved by the University of North Carolina Hospital Institutional Review Board.
CASE PRESENTATIONS
Case 1. An 11-yr-old, previously healthy, African American female presented to her local emergency room with lethargy, emesis, and a 3-day history of malaise. Physical examination was significant for obesity (80 kg), body mass index Ͼ95%, slurred speech, tachycardia (pulse of 166 beats/min), normotension, and acanthosis nigricans. Other vital signs and physical exam findings were unremarkable. The patient was adopted and the family history was unknown.
Laboratory tests revealed a blood glucose of 77 mmol/L (1390 mg/dL) and an elevated sodium (Table 2) . Tests were not performed for urine ketones. An initial pH was 7.11 with bicarbonate of 11 mmol/L (11 mEq/L) and base deficit of 24.7 mmol/L. Blood urea nitrogen and creatinine were elevated. Other electrolytes were normal. Treatment included a single 1-L 0.9% saline bolus (12.5 mL/ kg), followed by 0.45% saline at 100 mL/ hr. After an 8-unit bolus of intravenous insulin, she was started on an 8-unit/hr insulin infusion. Her mental status initially did not deteriorate. After 5 hrs, her glucose dropped to 37 mmol/L (667 mg/ dL) and her pH normalized, but her sodium remained elevated (171 mmol/L [171 mg/dL] corrected for glucose). Urine output was Ͼ1 mL/kg/hr. Two head computed tomography (CT) scans 10 hrs apart showed no cerebral edema. Over the next 15 hrs, the patient became progressively more hypernatremic and less hyperglycemic. Her urine output diminished and she became obtunded and unable to follow commands. At that point, her intravenous fluids were changed to 0.33% saline at 200 mL/hr, but she rapidly developed increasing lactic acidosis and respiratory failure and died. A postmortem examination revealed no other condition that would explain the rapid and fatal course of her disease.
Case 2. A 12-yr-old, previously healthy, African American male presented to a local emergency room because of a recent alteration in his mental status and a 4-day history of malaise, nausea, vomiting, and diarrhea. His mother reported that he had been experiencing polydipsia and nocturnal enuresis for approximately 4 -6 months before presentation. A few hours before arriving to the emergency room, his mother found him incoherent and wandering around the house. Both sets of grandparents had T2DM.
Physical examination was significant for obesity ( dL]), all other electrolytes were normal. A creatinine kinase was not obtained.
Treatment included the administration of 4 L of 0.9% saline over 4 hrs (30 mL/kg) and an insulin infusion at 10 units/hr. Four hours after presentation, he became obtunded with a Glasgow Coma Scale score of 8, requiring intubation. A head CT did not show cerebral edema, but because of the rapid clinical deterioration, he was initially treated with mannitol. He was transported to the regional pediatric intensive care unit while receiving 0.45% saline at 250 mL/ hr. An intracranial pressure monitor was placed with intracranial pressures ranging from 2 to 20 cm H 2 O (normal Ͻ20 cm H 2 O). Over the next day he developed rhabdomyolysis (creatinine kinase 15,862 units/L) and multiple-system organ failure requiring inotropes and hemodialysis. There were no other identifiable factors that appeared to contribute to the rhabdomyolysis such as seizures, sepsis, or a family history of malignant hyperthermia. Broad-spectrum antibiotics and antifungals were administered. Due to recurrent, spiking fevers (Ͼ40°C), dantrolene was started. Repeat head CT scans did not show cerebral edema. He appeared to stabilize and improve over the next week, allowing discontinuation of inotropes and dialysis. However, evidence of rhabdomyolysis remained, as well as continual diurnal fevers. Twelve days after admission, the patient suddenly developed lactic acidosis and renal failure. Magnesium, potassium, and phosphate were normal. He became hypotensive, experienced a fatal arrhythmia, and died despite resuscitation attempts, including antiarrythmics and transjugular pacing. Postmortem examination was declined.
Case 3. A 14-yr-old, previously healthy, African American male was admitted to a local emergency room for confusion and a 2-day history of vomiting. Physical examination was significant for obesity (101 kg), body mass index Ͼ97%, obtundation, tachycardia (pulse 141 beats/min), and hypotension (blood pressure 83/53 mm Hg). Respiratory rate was rapid. His extremities were cool with diminished pulses. He had acanthosis nigricans at his neck. Family history was significant for first-and second-degree relatives with T2DM.
Initial laboratory tests revealed blood glucose of 95 mmol/L (1710 mg/dL; Table  2 ) and a metabolic acidosis (pH 7.08, PCO 2 22.8 mm Hg, base deficit 21 mmol/L, HCO 3 6.9 mmol/L [6.9 mEq/L]). Sodium, blood urea nitrogen, and creatinine were elevated. Other electrolytes were normal. Urinalysis showed Ͼ55 mmol/L (Ͼ1000 mg/dL) glucose, and trace ketones were present. Urine output was 3 mL/kg/hr. Seven liters of 0.9% saline was administered over the first 10 hrs (70 mL/kg) and a 200-mL/hr infusion of 0.45% saline was started. Insulin was infused at 7 units/hr. His was intermittently disoriented and combative, requiring intubation in transit to the local pediatric intensive care unit. Vital signs and neurologic exam improved over the next day. Gradually, his pH and glucose normalized, and his sodium was corrected without becoming hyponatremic (minimum Na 145 mmol/L [145 mEq/L]). Two CT scans, one on admission and one the next day, showed no evidence of cerebral edema. By the second day of hospitalization, he was extubated and transferred to the pediatric ward in stable condition. Subsequent diagnostic laboratory tests revealed a C-peptide of 0.43 nmol/L, a glutamic acid decarboxylase antibody of 1.48 units/mL (normal Ͻ1.45 units/mL), an insulin autoantibody of Ͻ0.1 Kronus units/mL (normal, Ͻ0.4), and an islet cell antibody of Ͻ1:4 (normal Ͻ1:4), demonstrating a negative workup for type 1 diabetes mellitus. At outpatient follow-up, he was doing well and his insulin regimen was adjusted appropriately with the hope of starting oral hypoglycemic medicine at his next visit.
Case 4. A 9-yr-old, previously healthy, African American female presented to an outside hospital with a 5-day history of polydipsia, polyuria, polyphagia, and malaise. Physical examination was significant for obesity (60 kg) and body mass index Ͼ97%. She was tachycardic with a heart rate of 131 beats/min. Blood pressure was 111/75 mm Hg and respiratory rate was 65 breaths/min. She was lethargic but arousable. She had acanthosis nigricans at her neck. The patient's mother had T2DM.
Initial laboratory tests revealed a blood glucose of 100 mmol/L (1805 mg/ dL) ( Table 2 ) without significant metabolic acidosis (pH 7.21, PCO 2 46 mm Hg, base deficit 9 mmol/L, HCO 3 20 mmol/L [20 mEq/L]). Sodium, blood urea nitrogen, and creatinine were elevated. All other electrolytes were normal. A urinalysis showed glucose, but only trace ketones were present. Initial treatment included 2 L of 0.9% saline (33 mL/kg) and a 15-unit insulin bolus. She was started on 0.9% saline at 150 mL/hr and 5 units/hr of insulin. Initial urine output in the emergency room was 2 mL/kg/hr. She required intubation once she reached the tertiary care pediatric intensive care unit due to obtundation with a Glasgow Coma Scale score of 8. A head CT showed no cerebral edema. She received 9 L of 0.9% saline in the first 10 hrs (150 mL/ kg) and was subsequently maintained on 0.45% saline at 200 mL/hr. Insulin was continued at 5 units/hr. She was found to have rhabdomyolysis (creatinine kinase of 11,462 units/L). By 24 hrs after presentation she was extubated and transferred 48 hrs later to the pediatric ward in stable condition. Subsequent diagnostic laboratory tests revealed a C-peptide of 0.3 ng/mL, glutamic acid decarboxylase antibody of 0.0 nmol/L, insulin autoantibody of 0.5 units/mL, and an islet cell antibody of Ͻ0.8 units/mL, demonstrating a negative workup for type 1 diabetes. At the time of her discharge her creatinine kinase was 76 units/L. She was discharged home on 20 units of insulin glargine and 500 mg of metformin.
DISCUSSION
Our patients all presented with HHS as an initial manifestation of decompensated T2DM. All four had typical history and physical findings that helped to classify the patients as type 2 diabetics (Table  3) , including family history of T2DM, obesity, acanthosis nigricans, and presentation at puberty. Most patients with T2DM do not have the positive autoantibodies that are seen in type 1 diabetes (glutamic acid decarboxylase, islet cell antibody, insulin autoantibody). Patient 3 had a slightly positive glutamic acid decarboxylase antibody, but he had typical characteristics of T2DM.
The patients in our series all had HHS, despite differing levels of acidosis and diverse outcomes. All four patients presented with extreme hyperglycemia and hyperosmolality. In the context of unrecognized T2DM, our patients' hyperosmolar state was likely due to a profound and longstanding dehydration, although the (26) effects and nature of the fluids the patients had received before presentation would have affected the osmolality. Due to the obesity of our patients, the diagnosis of dehydration was difficult on physical exam. The markedly elevated blood urea nitrogen is supportive of hypovolemia at presentation. Although the first and third patients in our series presented with severe metabolic acidosis (pH of 7.11 and 7.08), their extreme hyperglycemia and hyperosmolality suggest HHS. This acidosis was likely a lactic acidosis from hypovolemia resulting in tissue hypoperfusion and impaired oxygenation. The typical metabolic triad of HHS is more evident in our second and fourth patients, both of whom presented with a moderate acidosis despite severe hyperglycemia. The presence of ketones and a significant acidosis in children should not preclude the diagnosis of HHS and may be a pitfall in initially diagnosing the disease. The mental status changes that were present in our patients are also typical of HHS. Changes in mental status parallel the extent of hyperosmolality, which correlates with the degree of dehydration (13) . In DKA, where the osmolality is typically lower, the reasons for mental status changes are controversial but may be due to osmolar shifts in the brain after treatment of hyperglycemia. Coma in HHS occurs when calculated osmolality exceeds 320 -340 mmol/kg (mOsm/kg) in adults; 20 -25% of adults with HHS present in a coma (13) . All four of our patients were at risk for coma on presentation, as all had calculated effective osmolality greater than this value.
The pathophysiology of HHS is useful to understand the etiology of its consequences. Hyperglycemia leads to glucosuria, diuresis, and dehydration, which decrease the concentrating capacity of the kidney (5) . An osmotic gradient is created, shifting fluid from the intracellular to extracellular fluid compartments. In the early stages of HHS, hyponatremia is present; however, as free-water diuresis continues, the serum sodium normalizes and hypernatremic dehydration ensues. Hyperosmolality, with both intracellular and extracellular dehydration, develops as free water is lost. The extreme hypovolemia causes release of glucagon, epinephrine, cortisol, and growth hormone, which further exacerbate the hyperglycemic response and dehydration in HHS. It is estimated that there is approximately 15-20% of total body water loss in HHS, compared with 10% in DKA (4). This severe hypovolemia is attributed to the more gradual onset of HHS compared with DKA, allowing a longer time for metabolic derangement. Patients with DKA typically present earlier due to the clinical effects of ketosis.
In the management of HHS, the rate of fluid replacement has not been studied in pediatrics but perhaps is the most critical element of treatment. Children presenting with HHS are typically treated similarly to children with DKA as no other treatment guidelines exist. As indicated in a recent consensus statement for DKA (19) , fluid rates are rarely in excess of twice maintenance. Adult studies of patients with HHS have demonstrated that slowing fluid resuscitation to avoid cerebral edema was not advantageous and had deleterious outcomes (5, 13) . In adults, death associated with HHS in Ͻ72 hrs is most often due to shock or sepsis rather than premorbid conditions. Rapid fluid correction is the standard of care in patients, and approximately 1 L of isotonic fluid per hour is recommended initially. Therefore, exceeding the fluid rates recommended for DKA may, in fact, not be deleterious in these adolescents because of the relatively greater degree of dehydration and propensity for shock. However, in a recent case report of a child with HHS, it was observed that during rehydration, the correction of serum glucose was more rapid than that of cerebral glucose, potentiating the risk of osmotic shifts in the brain (17) . It is unclear if the recommendations for adult patients with HHS apply to children with less long-standing comorbidity. Nevertheless, until there are sufficient data to suggest that rapid fluid replacement is harmful in adolescents with HHS, we must defer to the adult experience.
The amount and type of fluids used for rehydration are less controversial. The typical total body water loss in HHS is approximately 15-20%, which represents about 12% of body weight, or a deficit of 9 L in a person Ͼ70 kg. This represents a greater degree of dehydration than seen in diabetic ketoacidosis, which is approximately 6 L for a person Ͼ70 kg (4, 5) . It is known that 0.9% saline is hypotonic or isotonic in patients with HHS and should be used to expand intracellular volume and increase tissue perfusion. There is some question, however, whether this increases the sodium load excessively if given rapidly (20) . Administration of large volumes of 0.9% saline might increase the serum sodium if urinary losses of sodium are low, exacerbating the elevated osmolality. On the other hand, 0.9% saline would be required in hypernatremic dehydration if the goal were to replace the solute deficit before the free water deficit to prevent a decrease in the sodium and avoid rapid changes in osmolality. On balance, it is advisable to initially bolus with 0.9% saline and closely monitor sodium levels, decreasing the percent saline if the sodium rises. The quantification of urine output, urine sodium levels, sodium intakes, and pre-and postresuscitation weights may be examples of prospective data to help clarify optimal management for future pediatric patients with HHS.
The patients presented here were treated with 0.9% saline and insulin, yet treatment differed in the volumes of fluid given to each patient. Patient 1 was treated with conservative fluid resuscitation, as is recommended for patients with DKA. The diagnosis of HHS was not recognized in this patient at presentation. Patients 2, 3, and 4 received approximately 1 L/hr for the first 5-10 hrs after presentation. Patients 3 and 4 survived, despite increases in sodium levels after 0.9% saline administration in both patients. Patient 2 died in late stages of management, and fluid resuscitation did not play a major role in the etiology of his death. There was no radiologic evidence of cerebral edema in any of the four patients.
Two of our patients had evidence of rhabdomyolysis. Unfortunately, a creatinine kinase level was not obtained in the other two patients so it is not known whether they had evidence of this disorder. Rhabdomyolysis is diagnosed by a creatinine kinase Ͼ1000 IU/L. It has recently received attention in pediatrics as a result of a case series describing six adolescent males with HHS and rhabdomyolysis similar to our second patient (14) . The authors postulate that the rhabdomyolysis is the result of a malignant hyperthermia-like syndrome precipitated by a preservative used in insulin preparations. Four of the six patients in this series died, three of fatal arrhythmias. Although our second patient's hemodynamic instability and renal failure improved over time, his creatinine kinase remained persistently elevated and he remained febrile with multiple negative blood and urine cultures. He, too, died of a fatal arrhythmia of unknown etiology. Our fourth patient, while showing evidence of rhabdomyolysis, did not have accompanying high fevers. An investigation for other causes for elevated creatinine kinase, such as endocrinopathies or infection, was negative. One comparable case report describes a female HHS patient with rhabdomyolysis and extreme hypernatremia who was also afebrile and completely recovered (18) . There is evidence that hyperosmolality in itself predisposes to the development of rhabdomyolysis (21) (22) (23) . Adults with HHS and elevated creatinine kinase are known to have an increased mortality rate (26.7% vs. 38.5%) (5, 24) .
CONCLUSION
Pediatric HHS is an uncommon and potentially fatal entity. With increasing rates of childhood obesity and pediatric T2DM, the incidence of HHS may increase. HHS may be the first presentation of diabetes as illustrated in our cases. Due to the high mortality rate and complication risk, it is essential that the general pediatrician, pediatric emergency physician, and pediatric intensivist increase their index of suspicion to include HHS as one end of a spectrum in patients who present with hyperglycemia and dehydration. Unfortunately, the evidence for the initial resuscitation and management of pediatric HHS is limited to data extrapolated from adult literature and sporadic pediatric case reports. Pediatric HHS patients may require more rapid fluid administration than do patients with DKA because of the risk of hypovolemic shock associated with the degree of dehydration. The risk of cerebral edema during fluid administration in HHS is unclear. Prospective trials evaluating rates of fluid resuscitation are necessary. It is also evident that rhabdomyolysis is a complication of this syndrome, whether related to the metabolic disturbances associated with HHS or their treatment. Rhabdomyolysis should be suspected and treated in each patient with HHS.
